Comparison of Injectable Doxorubicin & Its Nanodrug Complex Chemotherapy for the Treatment of 4-Nitroquinoline-1-Oxide Induced Oral Squamous Cell Carcinoma in Rats Publisher Pubmed



Khiavi MM¹ ; Abdal K² ; Abbasi MM³ ; Hamishehkar H³ ; Aghbali AA² ; Salehi R⁴ ; Sina M² ; Abdollahi B³ ; Fotohi S³ Show Affiliations
Source: Indian Journal of Medical Research Published:2017

Abstract

Background & objectives: Combination treatments of chemotherapy and nanoparticle drug delivery have shown significant promise in cancer treatment. The aim of the present study was to compare the efficacy of a nanodrug complex with its free form in the treatment of tongue squamous cell carcinoma induced by 4-nitroquinoline-1-oxide in rats. Methods: In this study, 75 male Sprague-Dawley rats were divided into five groups. Oral squamous cell carcinoma (OSCC) was induced by using 4- nitroquinoline-1-oxide (4NQO) as a carcinogen. Newly formulated doxorubicin (DOX)-methotrexate (MTX)-loaded nanoparticles, and free DOX-MTX were administrated intravenously to rats. During the study, the animals were weighed once a week. At the end of the treatment, rats’ tongues were evaluated histopathologically. Results: There was significant difference between the mean weight of rats in groups A and B (P=0.001) and also groups A and K (P<0.001). No significant association was found between the mortality rate of groups. The difference between the severity of dysplasia of treated and untreated groups was significant (P<0.001). Interpretation & conclusions: Our study showed that DOX-MTX nanoparticle complex was more effective than free DOX-MTX in chemotherapy treatment of oral squamous cell carcinoma in rat models. Further investigations are necessary to clarify the advantages and disadvantages of the nanoparticle complex and its potential therapeutic application for different types of cancer. © 2017, Indian Council of Medical Research. All rights reserved.